HERVolution Therapeutics

HERVolution Therapeutics engineers novel immunotherapies that target HERV antigens from the human genome to treat cancer, metabolic disease, and other aging-related diseases. The company's proprietary approach breaks "self" tolerance, making these antigens visible to the immune system and enabling potent and durable anti-HERV immune responses. Their pipeline of off-the-shelf therapies offers potential improvements for the aging population.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $11.7M

Date: 19-Dec-2024

Investors: Serum Institute of India (SII), European Innovation Council (EIC) Fund

Markets: Biotechnology, Immunology, Oncology, Metabolic Disease, Genetics, Biopharma

HQ: Copenhagen, Denmark

Founded: 2018

Website: https://hervolutiontx.com/

LinkedIn: https://www.linkedin.com/company/hervolutiontx

Twitter: https://x.com/Hervolutiontx

Instagram: